Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas

K P Raj; J A Zell; C L Rock; C E McLaren; C Zoumas-Morse; E W Gerner; F L Meyskens

doi:10.1038/bjc.2013.15

Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas

British Journal of Cancer ◽

10.1038/bjc.2013.15 ◽

2013 ◽

Vol 108 (3) ◽

pp. 512-518 ◽

Cited By ~ 31

Author(s):

K P Raj ◽

J A Zell ◽

C L Rock ◽

C E McLaren ◽

C Zoumas-Morse ◽

...

Keyword(s):

Clinical Trial ◽

Colorectal Adenomas ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Dietary Polyamines

Download Full-text

Role of dietary polyamines in a phase III clinical trial of DFMO and sulindac for prevention of metachronous colorectal adenomas.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1523 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1523-1523 ◽

Cited By ~ 2

Author(s):

K. P. Raj ◽

J. A. Zell ◽

C. L. Rock ◽

C. E. McLaren ◽

C. Zoumas-Morse ◽

...

Keyword(s):

Clinical Trial ◽

Colorectal Adenomas ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Dietary Polyamines

Download Full-text

NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps1141 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS1141-TPS1141 ◽

Cited By ~ 16

Author(s):

Eleftherios P. Mamounas ◽

Julia R. White ◽

Hanna Bandos ◽

Thomas B. Julian ◽

Atif J. Kahn ◽

...

Keyword(s):

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Chest Wall ◽

Phase Iii ◽

Phase Iii Clinical Trial

Download Full-text

A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer — Anglo Celtic VII

Clinical Oncology ◽

10.1016/j.clon.2015.04.033 ◽

2015 ◽

Vol 27 (8) ◽

pp. 460-464 ◽

Cited By ~ 12

Author(s):

P. Canney ◽

E. Murray ◽

J. Dixon-Hughes ◽

L.-A. Lewsley ◽

J. Paul

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Cranial Radiotherapy ◽

Phase Iii Clinical Trial ◽

Trial Testing

Download Full-text

Longitudinal Assessment of Air Conduction Audiograms in a Phase III Clinical Trial of Difluoromethylornithine and Sulindac for Prevention of Sporadic Colorectal Adenomas

Cancer Prevention Research ◽

10.1158/1940-6207.capr-08-0074 ◽

2008 ◽

Vol 1 (7) ◽

pp. 514-521 ◽

Cited By ~ 22

Author(s):

Christine E. McLaren ◽

Sharon Fujikawa-Brooks ◽

Wen-Pin Chen ◽

Daniel L. Gillen ◽

Daniel Pelot ◽

...

Keyword(s):

Clinical Trial ◽

Colorectal Adenomas ◽

Phase Iii ◽

Longitudinal Assessment ◽

Phase Iii Clinical Trial ◽

Air Conduction

Download Full-text

PF216 ROLE OF MEASURABLE RESIDUAL DISEASE (MRD) IN REDEFINING COMPLETE RESPONSE (CR) IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PETHEMA-FLUGAZA PHASE III CLINICAL TRIAL

HemaSphere ◽

10.1097/01.hs9.0000559080.00178.7d ◽

2019 ◽

Vol 3 (S1) ◽

pp. 59

Author(s):

B. Paiva ◽

D. Martínez-Cuadrón ◽

J.M. Bergua ◽

S. Vives ◽

L. Algarra ◽

...

Keyword(s):

Clinical Trial ◽

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Residual Disease ◽

Complete Response ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Measurable Residual Disease ◽

Acute Myeloid

Download Full-text

NIH Announces Phase III Clinical Trial of Creatine for Parkinson's Disease

PsycEXTRA Dataset ◽

10.1037/e607462007-001 ◽

2007 ◽

Keyword(s):

Parkinson’S Disease ◽

Clinical Trial ◽

Parkinson's Disease ◽

Phase Iii ◽

Phase Iii Clinical Trial

Download Full-text

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Download Full-text

Faculty Opinions recommendation of Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725828169.793561106 ◽

2019 ◽

Author(s):

Mark Bower

Keyword(s):

Clinical Trial ◽

Kaposi's Sarcoma ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Kaposi’S Sarcoma ◽

Phase Iii ◽

Phase Iii Clinical Trial

Download Full-text

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793551519 ◽

2018 ◽

Author(s):

Adil Bharucha

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Phase Iii Clinical Trial ◽

Chronic Idiopathic Constipation

Download Full-text

Faculty Opinions recommendation of A randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727289372.793528809 ◽

2017 ◽

Author(s):

Aldo Infantino

Keyword(s):

Clinical Trial ◽

Phase Iii ◽

Idiopathic Constipation ◽

Phase Iii Clinical Trial ◽

Chronic Idiopathic Constipation

Download Full-text